173 related articles for article (PubMed ID: 27071853)
41. Synergistic combination effect of cidofovir and idoxuridine on vaccinia virus replication.
Remichkova M; Petrov N; Galabov AS
Antivir Chem Chemother; 2006; 17(2):53-8. PubMed ID: 17042327
[TBL] [Abstract][Full Text] [Related]
42. Identification of AXL as a co-receptor for human parvovirus B19 infection of human erythroid progenitors.
Ning K; Zou W; Xu P; Cheng F; Zhang EY; Zhang-Chen A; Kleiboeker S; Qiu J
Sci Adv; 2023 Jan; 9(2):eade0869. PubMed ID: 36630517
[TBL] [Abstract][Full Text] [Related]
43. Different patterns of restriction to B19 parvovirus replication in human blast cell lines.
Gallinella G; Manaresi E; Zuffi E; Venturoli S; Bonsi L; Bagnara GP; Musiani M; Zerbini M
Virology; 2000 Dec; 278(2):361-7. PubMed ID: 11118359
[TBL] [Abstract][Full Text] [Related]
44. New Insights of Human Parvovirus B19 in Modulating Erythroid Progenitor Cell Differentiation.
Feng S; Zeng D; Zheng J; Zhao D
Viral Immunol; 2020 Oct; 33(8):539-549. PubMed ID: 32412895
[TBL] [Abstract][Full Text] [Related]
45. Towards the Antiviral Agents and Nanotechnology-Enabled Approaches Against Parvovirus B19.
Hu X; Jia C; Wu J; Zhang J; Jiang Z; Ma K
Front Cell Infect Microbiol; 2022; 12():916012. PubMed ID: 35795188
[TBL] [Abstract][Full Text] [Related]
46. Dissection of the Kaposi's sarcoma-associated herpesvirus gene expression program by using the viral DNA replication inhibitor cidofovir.
Lu M; Suen J; Frias C; Pfeiffer R; Tsai MH; Chuang E; Zeichner SL
J Virol; 2004 Dec; 78(24):13637-52. PubMed ID: 15564474
[TBL] [Abstract][Full Text] [Related]
47. Enhanced Cell-Based Detection of Parvovirus B19V Infectious Units According to Cell Cycle Status.
Ducloux C; You B; Langelé A; Goupille O; Payen E; Chrétien S; Kadri Z
Viruses; 2020 Dec; 12(12):. PubMed ID: 33353185
[TBL] [Abstract][Full Text] [Related]
48. Ether lipid ester derivatives of cidofovir inhibit polyomavirus BK replication in vitro.
Randhawa P; Farasati NA; Shapiro R; Hostetler KY
Antimicrob Agents Chemother; 2006 Apr; 50(4):1564-6. PubMed ID: 16569886
[TBL] [Abstract][Full Text] [Related]
49. The clinical use of parvovirus B19 assays: recent advances.
Gallinella G
Expert Rev Mol Diagn; 2018 Sep; 18(9):821-832. PubMed ID: 30028234
[TBL] [Abstract][Full Text] [Related]
50. Ether lipid-ester prodrugs of acyclic nucleoside phosphonates: activity against adenovirus replication in vitro.
Hartline CB; Gustin KM; Wan WB; Ciesla SL; Beadle JR; Hostetler KY; Kern ER
J Infect Dis; 2005 Feb; 191(3):396-9. PubMed ID: 15633099
[TBL] [Abstract][Full Text] [Related]
51. Comparison of the antiviral activities of alkoxyalkyl and alkyl esters of cidofovir against human and murine cytomegalovirus replication in vitro.
Wan WB; Beadle JR; Hartline C; Kern ER; Ciesla SL; Valiaeva N; Hostetler KY
Antimicrob Agents Chemother; 2005 Feb; 49(2):656-62. PubMed ID: 15673748
[TBL] [Abstract][Full Text] [Related]
52. The antiviral resistance and replication of cidofovir-resistant adenovirus variants in the New Zealand White rabbit ocular model.
Romanowski EG; Gordon YJ; Araullo-Cruz T; Yates KA; Kinchington PR
Invest Ophthalmol Vis Sci; 2001 Jul; 42(8):1812-5. PubMed ID: 11431446
[TBL] [Abstract][Full Text] [Related]
53. The genome of human parvovirus b19 can replicate in nonpermissive cells with the help of adenovirus genes and produces infectious virus.
Guan W; Wong S; Zhi N; Qiu J
J Virol; 2009 Sep; 83(18):9541-53. PubMed ID: 19587029
[TBL] [Abstract][Full Text] [Related]
54. Parvovirus B19 and erythroid cells.
Pillet S; Morinet F
Pathol Biol (Paris); 2002 Jun; 50(5):349-56. PubMed ID: 12116854
[TBL] [Abstract][Full Text] [Related]
55. Adenovirus vector-mediated RNA interference for the inhibition of human parvovirus B19 replication.
Brandt MR; Kirste AG; Pozzuto T; Schubert S; Kandolf R; Fechner H; Bock CT; Kurreck J
Virus Res; 2013 Sep; 176(1-2):155-60. PubMed ID: 23770153
[TBL] [Abstract][Full Text] [Related]
56. Hexadecyloxypropyl-cidofovir (CMX001) suppresses JC virus replication in human fetal brain SVG cell cultures.
Jiang ZG; Cohen J; Marshall LJ; Major EO
Antimicrob Agents Chemother; 2010 Nov; 54(11):4723-32. PubMed ID: 20823288
[TBL] [Abstract][Full Text] [Related]
57. Cidofovir on HHV-8 in BCBL-1 cells.
Pica F; Serafino A; Garaci E; Volpi A
Antivir Ther; 2004 Oct; 9(5):823-5. PubMed ID: 15535421
[No Abstract] [Full Text] [Related]
58. Inhibition of vaccinia virus replication by two small interfering RNAs targeting B1R and G7L genes and their synergistic combination with cidofovir.
Vigne S; Duraffour S; Andrei G; Snoeck R; Garin D; Crance JM
Antimicrob Agents Chemother; 2009 Jun; 53(6):2579-88. PubMed ID: 19307376
[TBL] [Abstract][Full Text] [Related]
59. Cidofovir and (S)-9-[3-hydroxy-(2-phosphonomethoxy)propyl]adenine are highly effective inhibitors of vaccinia virus DNA polymerase when incorporated into the template strand.
Magee WC; Aldern KA; Hostetler KY; Evans DH
Antimicrob Agents Chemother; 2008 Feb; 52(2):586-97. PubMed ID: 18056278
[TBL] [Abstract][Full Text] [Related]
60. Human parvovirus B19: a review.
Rogo LD; Mokhtari-Azad T; Kabir MH; Rezaei F
Acta Virol; 2014; 58(3):199-213. PubMed ID: 25283854
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
